Both Tph1 GKO and Htr2a LKO mice were effective only in HFD-induced liver steatosis without altering systemic energy homeostasis which suggest that blocking enterohepatic signaling pathways mediated by GDS and HTR2A represses TG accumulation in the liver. The gene discussed is HTR2A; the disease is Hepatic steatosis.